Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 889 for your search:
Drug:  docetaxel
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML18530, NCT00127933

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: XRP6976J_4001, NCT00280098

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MC#08-002, IIT 12230, NCT00883675

4.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML22780, 2009-014279-37, NCT01094184

5.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 21 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: DOCET_L_04775, U1111-1116-9574, NCT01107756

6.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: GEICAM/2009-02, 2010-022689-29, NCT01298193

7.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML25288, NCT01301729

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: GENTA-GN304, NCI-G01-2046, UCLA-0301058, NCT00030641

9.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NBCG10, REK 378-04-03133, NMA 03-07568, NCT00201435

10.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: XRP6976F_2503, NCT00261703

11.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: GEICAM/2006-14, Nº EudraCT 2007-007031-13, NCT00841828

12.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9090-08, NCT01348126

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 80 and under
Sponsor: Other
Protocol IDs: GER-AIO-01/92, EU-93011, NCT00002544

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AVENTIS-56976-TAX-311, RP-56976-TAX-311, NCI-V95-0680, NCT00002662

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: EORTC-62941

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95088, RP-56976-TAX-320, NCI-V96-0830

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-1594, E1594

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MRC-LU22, EORTC-08012, EU-97016, ISRCTN25582437, NCT00003159

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 69
Sponsor:
Protocol IDs: FRE-FNCLCC-PACS-01, EU-98044

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor:
Protocol IDs: SCTN-BR9809, EU-98053, NCT00003679

21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: RP-56976-TAX-326, RP-56976-V-326

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: EORTC-24971, RP-56976-V-323, NCT00003888

23.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SC-NN5-98-02-010

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CRC-BOC-SCOTROC, EU-99010, NCT00003998

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067211, S9916, U10CA032102, SWOG-S9916, CLB-99808, NCCTG-S9916, NCT00004001
1     
New Search